Does Dr. FARHAD ARDESHIRPOUR-ZARTOSHTI have financial conflicts of interest?

Dr. FARHAD ARDESHIRPOUR-ZARTOSHTI (M.D.) has received a total of $18,398 in pharmaceutical and medical device industry funding between 2021 and 2025. This includes $18,398 in personal promotional payouts (consulting, meals, travel) and $0 in clinical research grants. Financial ties do not automatically imply conflict of interest, but are disclosed under the Sunshine Act.

Which pharmaceutical companies pay Dr. FARHAD ARDESHIRPOUR-ZARTOSHTI?

According to CMS Open Payments data, Dr. FARHAD ARDESHIRPOUR-ZARTOSHTI received funding from GALDERMA LABORATORIES, L.P ($17,567), STRYKER CORPORATION ($307), and MERZ NORTH AMERICA ($244).

Does Dr. FARHAD ARDESHIRPOUR-ZARTOSHTI receive research grants or speaking fees?

Dr. FARHAD ARDESHIRPOUR-ZARTOSHTI has received $18,398 in general promotional payments (such as consulting honoraria, meals, and speaking fees) and $0 in clinical research grants.

DR. FARHAD ARDESHIRPOUR-ZARTOSHTI

M.D.Real-Time Hydrated

Specialty: Otolaryngology, Facial Plastic Surgery

Practice Location: BEVERLY HILLS, CA 90212

NPI Number: 1932376514

LIFETIME INDUSTRY VALUE

$18,398

2021 – 2025 Cumulative

Conflict of Interest Analysis

Dr. ARDESHIRPOUR-ZARTOSHTI is a verified Otolaryngology, Facial Plastic Surgery practitioner based in BEVERLY HILLS, CA.

Between 2021 and 2025, Dr. ARDESHIRPOUR-ZARTOSHTI had an overall industry promotional and research financial footprint of $18,398 as recorded in the federal CMS Open Payments database.

$18,398 was received in general payments, which include consultation fees, travel expenses, honoraria, and sponsored meals.
$0 was allocated to sponsored clinical trials and medical research activities.

Dr. ARDESHIRPOUR-ZARTOSHTI's primary funding source is GALDERMA LABORATORIES, L.P, which accounts for $17,567 (representing 95.5% of overall industry footprint).

Data coverage: 2021 – 2025 · Source: CMS Open Payments · CMS publishes each year's data around June 30 of the following year.

Payout Trend Over Time

General Payments

Research Funding

Top Funding Entities

Pharmaceutical & Device Manufacturers making direct payments

GALDERMA LABORATORIES, L.P

Rank 1

$17,567

95.5%

STRYKER CORPORATION

Rank 2

$307

1.7%

MERZ NORTH AMERICA

Rank 3

$244

1.3%

Itemized Transaction Archives

Direct live query to Socrata CMS Open Payments API (Bypasses local DB)

Year:

2025

Filter < $250

Click "Load Live Logs" to query the federal Open Payments registry directly.

Frequently Asked Questions

Answers compiled using federal transparency disclosure records under the Sunshine Act.